We propose to examine four inter-related pathogenic pathways for prostate carcinogenesis: the vitamin D axis, inflammation, sex steroids, and insulin/insulin-like growth factor signaling. We hypothesize that many of the proposed modifiable factors for prostate cancer (intakes of vitamin D, calcium, milk, antioxidants, n-3 fatty acids, polyunsaturated fat, hyperinsulinemic diets, obesity, anti-inflammatory agents) may operate through these pathways. A better understanding of how modifiable risk factors in conjunction with genetic susceptibility operate through these mechanisms can help optimize preventive strategies for prostate cancer. In addition, prostate cancers exhibit a profound range of heterogeneity in biologic potential for progression among tumors. We hypothesize that this heterogeneity is related to acquired molecular characteristics in the tumor. Thus, we will additionally examine dietary and hormonal factors that are identified to be related to aggressive behavior in prostate cancer in relation to specific molecular characteristics that determine biologic aggressive potential, such as differentiation and angiogenesis. In addition, we will examine whether identified dietary and other modifiable risk factors can, in the post-diagnostic period, influence survival among men treated with prostatectomy for apparently organ-confined prostate cancer. To accomplish our aims to dietary, hormonal, and genetic factors related to prostate cancer incidence and progression, we will use data in the Health Professionals Follow-up Study (HPFS), a cohort of the 47,000 men free of cancer at baseline in 1986. We project 5,502 new cases of prostate cancer by 2008, including 579 fatal cases, with tumor blocks from over 1,700 prostatectomy cases. The sources of the exposure data in the HPFS are (1) questionnaire, including diet, anthropometric measures, activity, medication use, (2) plasma samples, and (3) DMA. The outcome data will be based on (1) medical record and pathology report review for initial diagnosis and survival, and (2) tissue block markers that correlated with disease progression. We will use multivariate analysis to control for confounding factors. This project is likely to yield important new findings that may help our understanding of modifiable risk factors for prostate cancer incidence, progression, and survival. Our ultimate goal is to better understand how dietary and other modifiable factors, including widely used medications such as aspirin and statins, influence prostate carcinogenesis at various stages, including after diagnosis, and to identify the susceptible men who would be most likely to benefit from specific dietary and lifestyle changes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA055075-18
Application #
7849738
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
18
Fiscal Year
2009
Total Cost
$516,807
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Tabung, Fred K; Wang, Weike; Fung, Teresa T et al. (2018) Association of dietary insulinemic potential and colorectal cancer risk in men and women. Am J Clin Nutr 108:363-370
Grasso, Catherine S; Giannakis, Marios; Wells, Daniel K et al. (2018) Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer Discov 8:730-749
Song, Mingyang; Wu, Kana; Meyerhardt, Jeffrey A et al. (2018) Fiber Intake and Survival After Colorectal Cancer Diagnosis. JAMA Oncol 4:71-79
Ashar, Foram N; Mitchell, Rebecca N; Albert, Christine M et al. (2018) A comprehensive evaluation of the genetic architecture of sudden cardiac arrest. Eur Heart J 39:3961-3969
Jeon, Jihyoun; Du, Mengmeng; Schoen, Robert E et al. (2018) Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology 154:2152-2164.e19
Joshu, Corinne E; Peskoe, Sarah B; Heaphy, Christopher M et al. (2018) Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells. Prostate 78:233-238
Wang, Xiaoliang; Chan, Andrew T; Slattery, Martha L et al. (2018) Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk. Cancer Res 78:4790-4799
Yuan, Changzheng; Spiegelman, Donna; Rimm, Eric B et al. (2018) Relative Validity of Nutrient Intakes Assessed by Questionnaire, 24-Hour Recalls, and Diet Records as Compared With Urinary Recovery and Plasma Concentration Biomarkers: Findings for Women. Am J Epidemiol 187:1051-1063
Bhagwandin, Candida; Ashbeck, Erin L; Whalen, Michael et al. (2018) The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner. PLoS One 13:e0204898
Petimar, Joshua; Tabung, Fred K; Valeri, Linda et al. (2018) Mediation of Associations Between Adiposity and Colorectal Cancer Risk by Inflammatory and Metabolic Biomarkers. Int J Cancer :

Showing the most recent 10 out of 993 publications